New Name for PCOS Aims to Reflect Whole-Body Impact of Condition

Health specialists in Jersey argue that renaming a metabolic disorder affecting over 170 million women worldwide better captures its nature as a systemic issue, rather than limiting its scope to the ovaries. Consequently, Polycystic Ovary Syndrome (PCOS) has been officially rebranded as Polyendocrine Metabolic Ovarian Syndrome (PMOS). According to the International PCOS Network, the change, which took effect on May 12, is intended to enhance public understanding, thereby facilitating more accurate diagnoses and improved treatment outcomes.

Jessica Pinel, a nutritionist and chair of PCOS Jersey, emphasized that the previous terminology was misleading. Diagnosed three years ago following an expenditure of over £3,000 on treatments, Pinel noted that the term PCOS suggested the condition was confined to ovarian function. "We know that it is a full-body condition," she stated, contrasting this with the narrow perception implied by the old name.

The NHS outlines that individuals with PCOS or PMOS typically experience elevated male hormone levels, alongside symptoms such as weight gain and irregular menstrual cycles. Pinel, who supports numerous patients, highlighted the extensive variety of symptoms that significantly disrupt daily life. These can include fatigue, unwanted hair growth, acne, "brain fog," irregular periods, and infertility. "It is that full-body condition with a range of different symptoms," Pinel explained. "Hopefully, [the name change] allows more women to get support and treatment for that range of different symptoms because the condition affects us in unique ways."

Pinel stressed the urgent need for better education, noting that women often struggle with the vast amount of misinformation circulating on social media platforms like TikTok, Instagram, and Facebook. She pointed out that in 2024, the BBC exposed influencers marketing counterfeit cures for PCOS. Consequently, she advises anyone suspecting they have the condition to pursue professional medical guidance.

Regarding diagnosis, Pinel encouraged patients to advocate for themselves. "In terms of diagnosis, you are always entitled to a second opinion," she said. Recalling her own journey, she admitted she was not diagnosed correctly initially and had to undergo exploratory tests before seeking a secondary opinion. "If you feel like you're not being seen or heard, then please go and seek that second opinion because you deserve it."

Jersey GP Dr. Jessica Langtree-Marsh described PCOS/PMOS as a condition that is both "hugely under-researched and hugely misunderstood." She argued that early diagnosis and patient education are critical to ensuring appropriate individual care. Langtree-Marsh criticized the medical community for often overlooking the condition until a patient wishes to conceive, stating, "We see it as just simply: 'Come back when you want to have a baby and we'll fix it then.' Actually, we need to look at this as a lifespan condition."

The Jersey government has confirmed that a women’s health strategy, mandated by the Government Plan, is scheduled for publication later this year.

Dr. Langtree-Marsh also provided historical context, noting that the condition was identified 70 years ago by two male surgeons, Dr. Irving Stein and Dr. Michael Leventhal. While examining the ovaries of women with absent periods, they observed specific characteristics and initially named it Stein-Leventhal Syndrome. The name was later changed to PCOS, which Langtree-Marsh argues incorrectly implied the disorder was limited to the ovaries.

The rebranded term PMOS seeks to rectify this by acknowledging the condition's broader impact on women’s health. "The rebranded PMOS is trying to appreciate that it affects women more generally rather than just the ovaries, so that it's a whole body condition," she said. Although she admitted the new name is cumbersome, she welcomed the shift in definition. Langtree-Marsh expressed hope that the change would encourage a wider approach to treatment, moving beyond the sole reliance on contraceptive pills and incorporating metabolic medications to better combat the disorder.

Source: BBC News Generated at: 2026-05-26 05:27:03 UTC